| Date Filed | Type | Description |
| 05/18/2023 |
4
| BEN-MAIMON CAROLE (President and CEO) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $3.705, valued at
$18.5k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2022 |
4
| BEN-MAIMON CAROLE (President and CEO) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Bought 31,746 shares
@ $3.15, valued at
$100k
|
|
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2022 |
4
| BEN-MAIMON CAROLE (President and CEO) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 182,000 options to buy
@ $8.75, valued at
$1.6M
|
|
| 07/22/2021 |
4
| BEN-MAIMON CAROLE (Director) has filed a Form 4 on Teligent, Inc.|
Txns:
| Granted 150,000 restricted stock units
@ $0 |
|
| 01/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2020 |
3
| BEN-MAIMON CAROLE (President and CEO) has filed a Form 3 on Larimar Therapeutics, Inc. |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| BEN-MAIMON CAROLE (Director) has filed a Form 4 on Teligent, Inc.|
Txns:
| Granted 15,385 options to buy
@ $0.65, valued at
$10k
|
|
| 05/31/2019 |
4
| BEN-MAIMON CAROLE (Director) has filed a Form 4 on Teligent, Inc.|
Txns:
| Bought 10,000 shares
@ $0.5885, valued at
$5.9k
|
|
| 05/15/2019 |
4
| BEN-MAIMON CAROLE (Director) has filed a Form 4 on Teligent, Inc.|
Txns:
| Granted 10,901 options to buy
@ $0.86, valued at
$9.4k
Granted 11,628 options to buy
@ $0.86, valued at
$10k
|
|
| 01/04/2019 |
4
| BEN-MAIMON CAROLE (Director) has filed a Form 4 on Teligent, Inc.|
Txns:
| Granted 20,000 options
@ $1.32, valued at
$26.4k
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/13/2017 |
4
| BEN-MAIMON CAROLE (Director) has filed a Form 4 on Teligent, Inc.|
Txns:
| Bought 1,400 shares
@ $3.4784, valued at
$4.9k
Bought 3,600 shares
@ $3.483, valued at
$12.5k
|
|
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/31/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/31/2016 |
3
| BEN-MAIMON CAROLE (Director) has filed a Form 3 on Teligent, Inc. |
| 10/28/2013 |
4
| BEN-MAIMON CAROLE (President, Global Pharm.) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Exercised 6,734 options to buy
@ $18.93, valued at
$127.5k
|
|
| 10/15/2013 |
4
| BEN-MAIMON CAROLE (President, Global Pharm.) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Exercised 5,282 options to buy
@ $18.93, valued at
$100k
|
|
| 05/28/2013 |
4
| BEN-MAIMON CAROLE (President, Global Pharm.) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Paid exercise price by delivering 399 shares
@ $18.6, valued at
$7.4k
|
|
| 10/29/2012 |
4
| BEN-MAIMON CAROLE (President, Global Pharm.) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Paid exercise price by delivering 1,836 shares
@ $24.34, valued at
$44.7k
|
|
| 05/25/2012 |
4
| BEN-MAIMON CAROLE (President, Global Pharm. Div.) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Granted 4,333 shares
@ $0
Granted 10,833 options to buy
@ $20.9, valued at
$226.4k
|
|
| 11/01/2011 |
4
| BEN-MAIMON CAROLE (President, Global Pharm. Div.) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Granted 24,000 shares
@ $0
Granted 75,000 options to buy
@ $18.93, valued at
$1.4M
|
|
| 09/13/2011 |
3
| BEN-MAIMON CAROLE (President, Global Pharm. Div.) has filed a Form 3 on IMPAX LABORATORIES INC |